Evidence
Clinical, Operational & Technical Evidence
Early results from pilot deployments, reported with the evaluation context required to interpret them.
κ > 0.90
Cohen's Kappa
Pilot result. Study design and population available upon request.
~60%
Reduction in evaluated workflow time
Measured against the defined evaluation endpoint for the pilot workflow.
50+
Participants pre-screened
Participant operations to date.
Technical — Reserved
Space reserved for future validated technical measurements as they clear internal review:
Retrieval latencyStructured extraction performanceThroughputMemory efficiencyPersistenceEvidence retrievalSystem availability
Traction
Early Evidence. Accelerating Momentum.
Commercial Traction
- Clinical Research of Philadelphia
- PharmD Live
- Corrielus Cardiology
Strategic Partnerships
- NVIDIA — Healthcare Data/AI Infrastructure Collaboration
- Harvard Business School Foundry — Healthcare Data/AI Infrastructure Validation
- Temple University — Smart Dermatoscope Development
- WPI/Practice Point — MyMo Robot (Autonomous Skin Disease Capture & Analysis)
Competitive Recognition
- NSF I-Corps Propelus
- Nasdaq Milestone Makers
- CTIP Finalist
- MeHI Primary Care Innovation Challenge Finalist
Market
Built for a Market Undergoing Structural Transformation
TAM
$11.1B
Global eClinical and CTMS market.
SAM
$640M
US high-volume research sites running sponsored trials.
SOM
$60M
Top 100 US oncology networks.
Figures reflect MyMonitor's internal market estimates and framing, not independently verified third-party research.
Build the Next Layer of Clinical Execution
Explore how MyMonitor can transform complex clinical workflows into structured, traceable execution.